Concepedia

Patricia LoRusso

PL

Statistics

Publications

341

Citations

29.3K

H-Index

80

Active since

1990

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Wayne State University

Yale Cancer Center

Yale University

Sarah Cannon

Patricia LoRusso is an author at The Barbara Ann Karmanos Cancer Institute specializing in oncology, pharmacology, and cancer pharmacology.

ORCID

Publications per year

1990–2025

341

Publications

341

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

D. Ross Camidge, Yung‐Jue Bang, Eunice L. Kwak et al. · The Lancet Oncology · 2012 · 1.3K citations

, , +15

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali et al. · Science Translational Medicine · 2012 · 1.1K citations

, , +17

Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma

Daniel D. Von Hoff, Patricia LoRusso, Charles M. Rudin et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

, , +17

Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449

Charles M. Rudin, Christine L. Hann, John Laterra et al. · New England Journal of Medicine · 2009 · 1K citations · Full text

, , +17

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer

Joseph McLaughlin, Gang Han, Kurt A. Schalper et al. · JAMA Oncology · 2015 · 839 citations · Full text

, , +17

1–5 of 341